Life Sciences

Seventure Partners invests in the start-up TIBOT Technologies, the pioneer in poultry robotics
9 October 2019

Seventure Partners invests in the start-up TIBOT Technologies, the pioneer in poultry robotics

TIBOT Technologies announces a 3-million-euro round of financing and the incorporation of new shareholders Demeter and Seventure Partners a pioneer in the Indian Poultry...

Read the press release
C-section babies are missing key microbes via nature.com
20 September 2019

C-section babies are missing key microbes via nature.com

How a baby is born has a profound impact on their microbiome — the community of microbes that colonize the body. That’s the finding of the largest ever study of the newborn...

Read more
Seventure Partners Life Sciences Corporate Update Health for Life: March 2019 – June 2019
1 July 2019

Seventure Partners Life Sciences Corporate Update Health for Life: March 2019 – June 2019

Seventure Partners, one of Europe’s leaders in financing innovation and a world-leader in life science microbiome investment, is pleased to provide an update on its Health...

Read the press release
String Bio Raises Capital to Develop and Manufacture Next-Generation Alternative Proteins in India
28 June 2019

String Bio Raises Capital to Develop and Manufacture Next-Generation Alternative Proteins in India

String Bio, a biotechnology company, announced today that it raised capital to develop next-generation alternate proteins for the global feed and food companies. The products...

Read the press release
LiMM Therapeutics incorporated to translate breakthrough science into first in class therapeutic agents
25 June 2019

LiMM Therapeutics incorporated to translate breakthrough science into first in class therapeutic agents

LiMM Therapeutics was created to lead development of a new class of therapeutic agents - neuronal reprogrammers of innate lymphocytes. The company is based on pioneering...

Read the press release
European Venture Capital Firm Seventure Partners renews its support to Domain Therapeutics and invests €3.5M ($3.9M) to prepare the next growth phase
28 May 2019

European Venture Capital Firm Seventure Partners renews its support to Domain Therapeutics and invests €3.5M ($3.9M) to prepare the next growth phase

Domain Therapeutics announces today that it has secured a €3.5M ($3.9M) investment from existing shareholder Seventure Partners, to accelerate its next growth phase. Since...

Read the press release
Vedanta Biosciences Closes Extended $45.5 Million Series C Financing
13 May 2019

Vedanta Biosciences Closes Extended $45.5 Million Series C Financing

Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human...

Read more
Vedanta Biosciences Key Microbiome Patent Upheld in European Opposition Proceedings
8 May 2019

Vedanta Biosciences Key Microbiome Patent Upheld in European Opposition Proceedings

Upheld patent EP2575835 covers therapeutic compositions of clostridial bacterial species derived from the human microbiome. Decision further solidifies Vedanta’s leading IP...

Read more
Mdoloris Announces CE Marking of the Analgesia Nociception Index (ANI®) Module for the Masimo Root® Patient Monitoring and Connectivity Hub
29 April 2019

Mdoloris Announces CE Marking of the Analgesia Nociception Index (ANI®) Module for the Masimo Root® Patient Monitoring and Connectivity Hub

ANI provides an objective, noninvasive, and continuous way to automatically monitor the pain level of patients. The Root platform, with its open architecture and built-in...

Read the press release